These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31403823)

  • 1. Clinical efficacy of sublingual immunotherapy tablets for allergic rhinitis is unlikely to be derived from
    Canonica GW; Devillier P; Casale T; Demoly P; Bos C; Karagiannis E; Passalacqua G; Wahn U; Mascarell L
    Expert Rev Clin Immunol; 2019 Sep; 15(9):921-928. PubMed ID: 31403823
    [No Abstract]   [Full Text] [Related]  

  • 2. The Importance of Tablet Formulation on Allergen Release Kinetics and Efficiency: Comparison of Freeze-dried and Compressed Grass Pollen Sublingual Allergy Immunotherapy Tablet Formulations.
    Lund K; Kito H; Skydtsgaard MB; Nakazawa H; Ohashi-Doi K; Lawton S
    Clin Ther; 2019 Apr; 41(4):742-753. PubMed ID: 30885398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergen Stability and Immunological Reactivity during Co-dissolution and Incubation of House Dust Mite and Japanese Cedar Pollen SLIT-Tablets.
    Watanabe A; Yamamoto T; Matsuhara H; Matsui H; Nakazawa H; Lund K; Ohashi-Doi K
    Biol Pharm Bull; 2020 Oct; 43(10):1448-1450. PubMed ID: 32759600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of House Dust Mite Allergens in Sublingual Allergy Tablets Is Highly Dependent on the Formulation.
    Ohashi-Doi K; Kito H; Du W; Nakazawa H; Ipsen H; Gudmann P; Lund K
    Int Arch Allergy Immunol; 2017; 174(1):26-34. PubMed ID: 28950271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grass pollen sublingual immunotherapy tablets provide long-term relief of grass pollen-associated allergic rhinitis and reduce the risk of asthma: findings from a retrospective, real-world database subanalysis.
    Devillier P; Wahn U; Zielen S; Heinrich J
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1199-1206. PubMed ID: 29072507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergen Release Profiles of Fast-Dissolving Freeze-Dried Orodispersible Sublingual Allergy Immunotherapy Tablets.
    Yamamoto T; Ohashi-Doi K; Matsuhara H; Verhoog L; Lindholm M; Lawton S; Lund K
    Curr Ther Res Clin Exp; 2022; 96():100678. PubMed ID: 35813554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-grass-pollen sublingual immunotherapy tablet for the treatment of grass-pollen-induced allergic rhinoconjunctivitis: 5 years of experience.
    Didier A; Wahn U; Horak F; Cox LS
    Expert Rev Clin Immunol; 2014 Oct; 10(10):1309-24. PubMed ID: 25205329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual Immunotherapy Dosing Regimens: What Is Ideal?
    Jin JJ; Li JT; Klimek L; Pfaar O
    J Allergy Clin Immunol Pract; 2017; 5(1):1-10. PubMed ID: 28065336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An observational, real-life safety study of a 5-grass pollen sublingual tablet in children and adolescents.
    Eberle P; Brueck H; Gall R; Hadler M; Sieber J; Karagiannis E
    Pediatr Allergy Immunol; 2014 Dec; 25(8):760-6. PubMed ID: 25378225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy With the SQ Tree SLIT-tablet in Adults and Adolescents With Allergic Rhinoconjunctivitis.
    Mäkelä MJ; Gyllfors P; Valovirta E; Steffensen MA; Grønager PM; Savolainen J; Winther L
    Clin Ther; 2018 Apr; 40(4):574-586.e4. PubMed ID: 29551533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Suggestions in Sublingual Immunotherapy for House Dust Mite- Related Allergic Diseases.
    Ferrando M; Bagnasco D; Passa-Lacqua G; Puggioni F; Varricchi G; Canonica GW
    Curr Pharm Biotechnol; 2017; 18(5):378-383. PubMed ID: 28413977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets.
    Nolte H; Casale TB; Lockey RF; Fogh BS; Kaur A; Lu S; Nelson HS
    J Allergy Clin Immunol Pract; 2017; 5(1):84-89.e3. PubMed ID: 27838323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effective Allergenic Reactivity of House Dust Mite Sublingual Immunotherapy Tablets Is Determined by Tablet Formulation.
    Kito H; Du W; Nakazawa H; Lund K; Ohashi-Doi K
    Biol Pharm Bull; 2019; 42(6):1030-1033. PubMed ID: 31155578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual grass and ragweed immunotherapy: Clinical considerations-a PRACTALL consensus report.
    Li JT; Bernstein DI; Calderon MA; Casale TB; Cox L; Passalacqua G; Pfaar O; Papadopoulos NG
    J Allergy Clin Immunol; 2016 Feb; 137(2):369-76. PubMed ID: 26371843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and tolerability of 5-grass pollen tablet sublingual immunotherapy: pooled analysis and clinical review.
    Didier A; Bons B
    Expert Opin Drug Saf; 2015 May; 14(5):777-88. PubMed ID: 25732009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update about Oralair® as a treatment for grass pollen allergic rhinitis.
    Klimek L; Brehler R; Mösges R; Demoly P; Mullol J; Wang DY; O'Hehir RE; Didier A; Kopp M; Bos C; Karagiannis E
    Hum Vaccin Immunother; 2022 Nov; 18(5):2066424. PubMed ID: 35704772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual Immunotherapy with a Five-Grass Pollen Tablet in Adult Patients with Allergic Rhinitis: An Open, Prospective, Noninterventional, Multicenter Study.
    Pfaar O; Richter HG; Klimek L; Sieber J; Hadler M; Karagiannis E
    Biomed Res Int; 2015; 2015():584291. PubMed ID: 26351635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases.
    Nolte H; Maloney J
    Allergol Int; 2018 Jul; 67(3):301-308. PubMed ID: 29759659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical benefits of treatment with SQ house dust mite sublingual tablet in house dust mite allergic rhinitis.
    Demoly P; Kleine-Tebbe J; Rehm D
    Allergy; 2017 Oct; 72(10):1576-1578. PubMed ID: 28273339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.